More on MANE
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $116.80 |
|
|||
| Open | $116.80 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $116.80 | ||||
| Day Low | $116.80 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 1,090 | ||||
- Veradermics (MANE) Reiterated at Overweight by Cantor Fitzgerald After Investor Dinner
- LifeSci Capital Starts Veradermics (MANE) at Outperform
- Achieve Life Sciences adds two board members ahead of drug resubmission
- Achieve Life Sciences Appoints Jeffrey Farrow and Reid Waldman, MD to Board of Directors
- Needham Starts Veradermics (MANE) at Buy
- Veradermics to Present at Upcoming June Investor Conferences
- Veradermics to present hair loss drug trial results at research congress
- Veradermics Announces Poster Presentation on Topline Results from Phase 2/3 ‘302’ Study of VDPHL01 at the 2026 World Congress for Hair Research
- Form SCHEDULE 13G/A Veradermics, Inc Filed by: VIKING GLOBAL INVESTORS LP
- Form D Veradermics, Inc
Entities mentioned with MANE
- FDA | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Jefferies & Co | View Related Stories »
- IPO | View Related Stories »
- Cantor Fitzgerald | View Related Stories »
- S1 | View Related Stories »
- Show More...
